Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-GPC3 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2017/159699
Kind Code:
A1
Abstract:
The disclosure provides compositions and methods for treating cancers. The methods comprising administering a PD-1 axis binding antagonist and an anti-GPC3 antibody. The compositions comprising a pharmaceutical composition for treating cancer which comprises a PD-1 axis binding antagonist and an anti-GPC3 antibody. Also disclosed are a pharmaceutical composition to be used in combination with a PD-1 axis binding antagonist for treating cancer which comprises an anti-GPC3 antibody as the active ingredient; and a pharmaceutical composition to be used in combination with an anti-GPC3 antibody for treating cancer which comprises as the active ingredient a PD-1 axis binding antagonist.

Inventors:
ENDO MIKA (JP)
KATO ATSUHIKO (JP)
OHTOMO TOSHIHIKO (JP)
ADACHI KENJI (JP)
KINOSHITA YASUKO (JP)
NARITA YOSHINORI (JP)
Application Number:
PCT/JP2017/010267
Publication Date:
September 21, 2017
Filing Date:
March 14, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHUGAI PHARMACEUTICAL CO LTD (JP)
GENENTECH INC (US)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C07K16/30
Domestic Patent References:
WO2015112805A12015-07-30
WO2015142675A22015-09-24
WO2017020812A12017-02-09
WO2010077634A12010-07-08
WO1993001161A11993-01-21
WO1998024893A21998-06-11
WO1996034096A11996-10-31
WO1996033735A11996-10-31
WO1991010741A11991-07-25
WO2007005874A22007-01-11
WO2013079174A12013-06-06
WO2011066389A12011-06-03
WO2006121168A12006-11-16
WO2009114335A22009-09-17
WO2009101611A12009-08-20
WO2010027827A22010-03-11
WO2011066342A22011-06-03
WO2010077634A12010-07-08
WO2010077634A12010-07-08
WO2007137170A22007-11-29
WO2003100429A22003-12-04
WO2006006693A12006-01-19
WO2007047291A22007-04-26
WO2009041062A12009-04-02
WO2009140242A12009-11-19
WO2007024249A22007-03-01
WO2007021841A22007-02-22
WO2006031370A22006-03-23
WO2000042072A22000-07-20
WO2004029207A22004-04-08
WO2004099249A22004-11-18
WO2006105338A22006-10-05
WO2007041635A22007-04-12
WO2008092117A22008-07-31
WO2005070963A12005-08-04
WO2006020114A22006-02-23
WO2006116260A22006-11-02
WO2006023403A22006-03-02
WO2014097648A12014-06-26
WO2006046751A12006-05-04
WO1993016185A21993-08-19
WO2008077546A12008-07-03
WO2000061739A12000-10-19
WO2001029246A12001-04-26
WO2003085119A12003-10-16
WO2003084570A12003-10-16
WO2005035586A12005-04-21
WO2005035778A12005-04-21
WO2005053742A12005-06-16
WO2002031140A12002-04-18
WO2004056312A22004-07-08
WO2003085107A12003-10-16
WO2003011878A22003-02-13
WO1997030087A11997-08-21
WO1998058964A11998-12-30
WO1999022764A11999-05-14
WO2006029879A22006-03-23
WO2005100402A12005-10-27
WO1999051642A11999-10-14
WO1994029351A21994-12-22
WO1990013646A11990-11-15
WO1994011026A21994-05-26
WO1990003430A11990-04-05
WO1987000195A11987-01-15
WO2006044908A22006-04-27
WO2015095418A12015-06-25
Foreign References:
EP2275135A12011-01-19
US8217149B22012-07-10
EP0404097A21990-12-27
US4816567A1989-03-28
US5545807A1996-08-13
US5545806A1996-08-13
US5569825A1996-10-29
US5625126A1997-04-29
US5633425A1997-05-27
US5661016A1997-08-26
US6982321B22006-01-03
US7087409B22006-08-08
US6075181A2000-06-13
US6150584A2000-11-21
US20130034559A12013-02-07
US7189826B22007-03-13
US20060258841A12006-11-16
US20060183887A12006-08-17
US20060059575A12006-03-16
US20050287149A12005-12-29
US20050100546A12005-05-12
US20050026229A12005-02-03
US7078492B22006-07-18
US7153507B22006-12-26
US20050176122A12005-08-11
US6919436B22005-07-19
US5750373A1998-05-12
US20050079574A12005-04-14
US20050119455A12005-06-02
US20050266000A12005-12-01
US20070117126A12007-05-24
US20070160598A12007-07-12
US20070237764A12007-10-11
US20070292936A12007-12-20
US20090002360A12009-01-01
US5821337A1998-10-13
US7527791B22009-05-05
US5770429A1998-06-23
US7041870B22006-05-09
US20070061900A12007-03-15
US5869046A1999-02-09
US5571894A1996-11-05
US5587458A1996-12-24
US5641870A1997-06-24
US6248516B12001-06-19
US20030157108A12003-08-21
US20040093621A12004-05-13
US20030115614A12003-06-19
US20020164328A12002-11-07
US20040132140A12004-07-08
US20040110704A12004-06-10
US20040110282A12004-06-10
US20040109865A12004-06-10
US6602684B12003-08-05
US20050123546A12005-06-09
US5500362A1996-03-19
US5821337A1998-10-13
US6737056B12004-05-18
US7332581B22008-02-19
US6194551B12001-02-27
US20050014934A12005-01-20
US7371826B22008-05-13
US5648260A1997-07-15
US5624821A1997-04-29
US4965199A1990-10-23
EP0073657A11983-03-09
US4419446A1983-12-06
US4601978A1986-07-22
DD266710A31989-04-12
US5648237A1997-07-15
US5789199A1998-08-04
US5840523A1998-11-24
EP0402226A11990-12-12
EP0183070A21986-06-04
EP0244234A21987-11-04
US5959177A1999-09-28
US6040498A2000-03-21
US6420548B12002-07-16
US7125978B12006-10-24
US6417429B12002-07-09
US4767704A1988-08-30
US4657866A1987-04-14
US4927762A1990-05-22
US4560655A1985-12-24
US5122469A1992-06-16
USRE30985E1982-06-29
US20050260186A12005-11-24
US20060104968A12006-05-18
US6267958B12001-07-31
US6171586B12001-01-09
Other References:
GHASSAN ABOU-ALF A ET AL: "Phase Ib study of RO5137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170). | 2014 ASCO Annual Meeting | Abstracts | Meeting Library", JOURNAL OR CLINICAL ONCOLOGY, vol. 32, 30 May 2014 (2014-05-30), pages 5s, XP055371653
YU SAWADA ET AL: "Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes", INTERNATIONAL JOURNAL OF ONCOLOGY, vol. 46, no. 1, 30 October 2014 (2014-10-30), GR, pages 28 - 36, XP055370119, ISSN: 1019-6439, DOI: 10.3892/ijo.2014.2737
ANONYMOUS ET AL: "A PHASE I STUDY OF CODRITUZUMAB, IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA", 22 July 2016 (2016-07-22), pages 1 - 2, XP055371632, Retrieved from the Internet [retrieved on 20170511]
A. X. ZHU ET AL: "First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma", CLINICAL CANCER RESEARCH, vol. 19, no. 4, 29 January 2013 (2013-01-29), pages 920 - 928, XP055207838, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-12-2616
LAFFERTY ET AL., AUST. J. EXP. BIOL. MED. SCI, vol. 53, 1975, pages 27 - 42
BRETSCHER ET AL., SCIENCE, vol. 169, 1970, pages 1042 - 1049
BRETSCHER, P.A., PROC. NAT. ACAD. SCI. USA, vol. 96, 1999, pages 185 - 190
JENKINS ET AL., J. EXP. MED., vol. 165, 1987, pages 302 - 319
LENSCHOW ET AL., ANN. REV. IMMUNOL., vol. 14, 1996, pages 233
OKAZAKI T ET AL., INTERN. IMMUN., vol. 19, no. 7, 2007, pages 813
THOMPSON RH ET AL., CANCER RES, vol. 66, no. 7, 2006, pages 3381
BLOOD, vol. 114, no. 8, 2009, pages 1537
SHARPE ET AL., NAT REV, 2002
KEIR ME ET AL., ANNU. REV. IMMUNOL., vol. 26, 2008, pages 677
ANGEW CHEM. INTL. ED. ENGL., vol. 33, 1994, pages 183 - 186
MENDELSOHN AND ISRAEL: "The Molecular Basis of Cancer", 1995, W.B. SAUNDERS, article MURAKAMI ET AL.: "Cell cycle regulation, oncogenes, and anti-neoplastic drugs (Chapter 1)", pages: 13
KABAT ET AL.: "Sequences of Proteins of Immunological Interest, 5th ed.", 1991, NATIONAL INSTITUTE OF HEALTH
ABBAS ET AL.: "Cellular and Mol. Immunology, 4th ed.", 2000, W.B. SAUNDERS, CO
PLUCKTHUN: "The Pharmacology of Monoclonal Antibodies", vol. 113, 1994, SPRINGER-VERLAG, pages: 269 - 315
HUDSON ET AL., NAT. MED, vol. 9, 2003, pages 129 - 134
HOLLINGER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 6444 - 6448
HUDSON ET AL., NAT. MED., vol. 9, 2003, pages 129 - 134
KOHLER; MILSTEIN, NATURE, vol. 256, 1975, pages 495 - 97
HONGO ET AL., HYBRIDOMA, vol. 14, no. 3, 1995, pages 253 - 260
HARLOW ET AL.: "Antibodies: A Laboratory Manual, 2nd ed.", 1988, COLD SPRING HARBOR LABORATORY PRESS
HAMMERLING ET AL.: "Monoclonal Antibodies and T-Cell Hybridomas", 1981, ELSEVIER, pages: 563 - 681
CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628
MARKS ET AL., J. MOL. BIOL., vol. 222, 1992, pages 581 - 597
SIDHU ET AL., J. MOL. BIOL., vol. 338, no. 2, 2004, pages 299 - 310
LEE ET AL., J. MOL. BIOL., vol. 340, no. 5, 2004, pages 1073 - 1093
FELLOUSE, PROC. NATL. ACAD. SCI. USA, vol. 101, no. 34, 2004, pages 12467 - 12472
LEE ET AL., J. IMMUNOL. METHODS, vol. 284, no. 1-2, 2004, pages 119 - 132
JAKOBOVITS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 2551
JAKOBOVITS ET AL., NATURE, vol. 362, 1993, pages 255 - 258
BRUGGEMANN ET AL., YEAR IN IMMUNOL., vol. 7, 1993, pages 33
MARKS ET AL., BIO/ TECHNOLOGY, vol. 10, 1992, pages 779 - 783
LONBERG ET AL., NATURE, vol. 368, 1994, pages 856 - 859
MORRISON, NATURE, vol. 368, 1994, pages 812 - 813
FISHWILD ET AL., NATURE BIOTECHNOL., vol. 14, 1996, pages 845 - 851
NEUBERGER, NATURE BIOTECHNOL., vol. 14, 1996, pages 826
LONBERG; HUSZAR, INTERN. REV. IMMUNOL., vol. 13, 1995, pages 65 - 93
MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851 - 6855
JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525
RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329
PRESTA, CURR. OP. STRUCT. BIOL., vol. 2, 1992, pages 593 - 596
VASWANI; HAMILTON, ANN. ALLERGY, ASTHMA & IMMUNOL., vol. 1, 1998, pages 105 - 115
HARRIS, BIOCHEM. SOC. TRANSACTIONS, vol. 23, 1995, pages 1035 - 1038
HURLE; GROSS, CURR. OP. BIOTECH, vol. 5, 1994, pages 428 - 433
HOOGENBOOM; WINTER, J. MOL. BIOL., vol. 227, 1991, pages 381
MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581
COLE ET AL.: "Monoclonal Antibodies and Cancer Therapy", 1985, ALAN R. LISS, pages: 77
BOERNER ET AL., J. IMMUNOL., vol. 147, no. 1, 1991, pages 86 - 95
VAN DIJK; VAN DE WINKEL, CURR. OPIN. PHARMACOL., vol. 5, 2001, pages 368 - 74
LI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 103, 2006, pages 3557 - 3562
XU ET AL., IMMUNITY, vol. 13, 2000, pages 37 - 45
JOHNSON; WU: "Methods in Molecular Biology", vol. 248, 2003, HUMAN PRESS, pages: 1 - 25
HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 448
SHERIFF ET AL., NATURE STRUCT. BIOL., vol. 3, 1996, pages 733 - 736
KABAT ET AL.: "Sequences of Proteins of Immunological Interest, 5th ed.", 1991, NATIONAL INSTITUTES OF HEALTH
CHOTHIA; LESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917
KABAT ET AL.: "Sequences of Immunological Interest, 5th ed.", 1991, NATIONAL INSTITUTES OF HEALTH
ZAPATA ET AL., PROTEIN ENG, vol. 8, no. 10, 1995, pages 1057 - 1062
COLIGAN ET AL.: "Current protocols in Immunology", 1993, article "Immunologic studies in humans (chapter 7)"
ALLEY ET AL., CURR. OPIN. CHEM. BIOL., vol. 14, 2010, pages 529 - 537
CHEN ET AL., J. MOL. BIOL., vol. 293, 1999, pages 865 - 881
KOHLER ET AL., NATURE, vol. 256, 1975, pages 495
NI, XIANDAI MIANYIXUE, vol. 26, no. 4, 2006, pages 265 - 268
VOLLMERS; BRANDLEIN, HISTOLOGY AND HISTOPATHOLOGY, vol. 20, no. 3, 2005, pages 927 - 937
VOLLMERS; BRANDLEIN, METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, vol. 27, no. 3, 2005, pages 185 - 91
GODING: "Monoclonal Antibodies: Principles and Practice", 1986, ACADEMIC PRESS, pages: 59 - 103
KOZBOR, J. IMMUNOL., vol. 133, 1984, pages 3001
BRODEUR ET AL.: "Monoclonal Antibody Production Techniques and Applications", 1987, MARCEL DEKKER, INC., pages: 51 - 63
EVEN ET AL., TRENDS IN BIOTECHNOLOGY, vol. 24, no. 3, 2006, pages 105 - 108
FRANEK, TRENDS IN MONOCLONAL ANTIBODY RESEARCH, 2005, pages 111 - 122
MUNSON ET AL., ANAL. BIOCHEM., vol. 107, 1980, pages 220
HOOGENBOOM ET AL.: "Methods in Molecular Biology", vol. 178, 2001, HUMAN PRESS, pages: 1 - 37
MCCAFFERTY ET AL., NATURE, vol. 348, pages 552 - 554
MARKS; BRADBURY: "Methods in Molecular Biology", vol. 248, 2003, HUMAN PRESS, pages: 161 - 175
WINTER ET AL., ANN. REV. IMMUNOL, vol. 12, 1994, pages 433 - 455
GRIFFITHS ET AL., EMBO J, vol. 12, 1993, pages 725 - 734
HOOGENBOOM; WINTER, J. MOL. BIOL, vol. 227, 1992, pages 381 - 388
ALMAGRO; FRANSSON, FRONT. BIOSCI., vol. 13, 2008, pages 1619 - 1633
QUEEN ET AL., PROC. NAT'LACAD. SCI. USA, vol. 86, 1989, pages 10029 - 10033
KASHMIRI ET AL., METHODS, vol. 36, 2005, pages 25 - 34
PADLAN, MOL. IMMUNOL., vol. 28, 1991, pages 489 - 498
DALL'ACQUA ET AL., METHODS, vol. 36, 2005, pages 43 - 60
OSBOURN ET AL., METHODS, vol. 36, 2005, pages 61 - 68
KLIMKA ET AL., BR. J. CANCER, vol. 83, 2000, pages 252 - 260
SIMS ET AL., J. IMMUNOL., vol. 151, 1993, pages 2296
CARTER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 4285
PRESTA ET AL., J. IMMUNOL, vol. 151, 1993, pages 2623
BACA ET AL., J. BIOL. CHEM., vol. 272, 1997, pages 10678 - 10684
ROSOK ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 22611 - 22618
LONBERG, CURR. OPIN. IMMUNOL, vol. 20, 2008, pages 450 - 459
LONBERG, NAT. BIOTECH., vol. 23, 2005, pages 1117 - 1125
KOZBOR, J. IMMUNOL, vol. 133, 1984, pages 3001
BOERNER ET AL., J. IMMUNOL., vol. 147, 1991, pages 86
MORIMOTO ET AL., JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, vol. 24, 1992, pages 107 - 117
BRENNAN ET AL., SCIENCE, vol. 229, 1985, pages 81
CARTER ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 163 - 167
CHOWDHURY, METHODS MOL. BIOL, vol. 207, 2008, pages 179 - 196
CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085
WRIGHT ET AL., TIBTECH, vol. 15, 1997, pages 26 - 32
OKAZAKI ET AL., J. MOL. BIOL., vol. 336, 2004, pages 1239 - 1249
YAMANE-OHNUKI ET AL., BIOTECH. BIOENG., vol. 87, 2004, pages 614
RIPKA ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 249, 1986, pages 533 - 545
KANDA, Y. ET AL., BIOTECHNOL. BIOENG., vol. 94, no. 4, 2006, pages 680 - 688
FERRARA ET AL., BIOTECHNOLOGY AND BIOENGINEERING, vol. 93, no. 5, 2006, pages 851 - 861
RAVETCH; KINET, ANNU. REV. IMMUNOL, vol. 9, no. 457-49, 1991, pages 464
HELLSTROM, I ET AL., PROC. NAT'LACAD. SCI. USA, vol. 83, 1986, pages 7059 - 7063
HELLSTROM, I ET AL., PROC. NAT'LACAD. SCI. USA, vol. 82, 1985, pages 1499 - 1502
BRUGGEMANN, M. ET AL., J. EXP. MED., vol. 166, 1987, pages 1351 - 1361
CLYNES ET AL., PROC. NAT'LACAD. SCI. USA, vol. 95, 1998, pages 652 - 656
GAZZANO-SANTORO ET AL., J. IMMUNOL. METHODS, vol. 202, 1996, pages 163
CRAGG, M.S ET AL., BLOOD, vol. 101, 2003, pages 1045 - 1052
CRAGG, M.S.; M.J. GLENNIE, BLOOD, vol. 103, 2004, pages 2738 - 2743
PETKOVA, S.B ET AL., INT'L. IMMUNOL, vol. 18, no. 12, 2006, pages 1759 - 1769
IDUSOGIE ET AL., J. IMMUNOL., vol. 164, 2000, pages 4178 - 4184
GUYER ET AL., J. IMMUNOL., vol. 117, 1976, pages 587
KIM ET AL., J. IMMUNOL., vol. 24, 1994, pages 249
DUNCAN; WINTER, NATURE, vol. 322, 1988, pages 738 - 40
STINCHCOMB ET AL., NATURE, vol. 282, 1979, pages 39
JONES, GENETICS, vol. 85, 1977, pages 12
VAN DEN BERG, BIO/TECHNOLOGY, vol. 8, 1990, pages 135
FLEER ET AL., BIO/TECHNOLOGY, vol. 9, 1991, pages 968 - 975
REYES ET AL., NATURE, vol. 297, 1982, pages 598 - 601
YANIV, NATURE, vol. 297, 1982, pages 17 - 18
CHARLTON: "Methods in Molecular Biology", vol. 248, 2003, HUMANA PRESS, pages: 245 - 254
GERNGROSS, NAT. BIOTECH, vol. 22, 2004, pages 1409 - 1414
LI ET AL., NAT. BIOTECH, vol. 24, 2006, pages 210 - 215
GRAHAM ET AL., J. GEN VIROL., vol. 36, 1977, pages 59
MATHER, BIOL. REPROD., vol. 23, 1980, pages 243 - 251
MATHER ET AL., ANNALS NY. ACAD. SCI., vol. 383, 1982, pages 44 - 68
URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 4216
YAZAKI; WU: "Methods in Molecular Biology", vol. 248, 2003, HUMANA PRESS, pages: 255 - 268
HAM ET AL., METH. ENZ., vol. 58, 1979, pages 44
BARNES ET AL., ANAL. BIOCHEM., vol. 102, 1980, pages 255
CARTER ET AL., BIO/ TECHNOLOGY, vol. 10, 1992, pages 163 - 167
LINDMARK ET AL., J. IMMUNOL. METH., vol. 62, 1983, pages 1 - 13
GUSS ET AL., EMBO J., vol. 5, 1986, pages 15671575
ED HARLOW AND DAVID LANE: "Antibodies, A Laboratory Manual", 1988, COLD SPRING HARBOR LABORATORY
CHAMPE ET AL., J. BIOL. CHEM., vol. 270, 1995, pages 1388 - 1394
OSOL, A.: "Remington's Pharmaceutical Sciences, 16th ed.", 1980
ISHIGURO T ET AL., CANCER RES., vol. 68, 2008, pages 9832 - 9838
SUZUKI ET AL., J TOXICOL SCI., vol. 27, 2002, pages 165 - 172
WATANABE ET AL., J TOXICOL PATHOL., vol. 28, 2015, pages 43 - 49
Attorney, Agent or Firm:
OHNO Seiji et al. (JP)
Download PDF: